Tactile Systems Technology, Inc. (NASDAQ: TCMD) Stock Competitors & Peer Comparison
See TCMD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TCMD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TCMD | $22.89 | +2.05% | 516.3M | 21.19 | $1.08 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $101.07 | -2.34% | 174.9B | 19.40 | $5.21 | +2.45% |
| MDT | $88.51 | -0.88% | 113.3B | 16.00 | $5.53 | +3.21% |
| SYK | $269.75 | -1.34% | 103.5B | 20.16 | $13.39 | +1.29% |
| BSX | $44.68 | +0.13% | 66.4B | 14.42 | $3.10 | N/A |
| EW | $85.73 | -1.26% | 49.4B | 31.74 | $2.70 | N/A |
| DXCM | $87.47 | -0.30% | 33B | 34.30 | $2.55 | N/A |
| GEHC | $66.38 | +0.44% | 30B | 14.56 | $4.56 | +0.21% |
| PHG | $24.55 | +0.41% | 24B | 14.02 | $1.75 | +4.05% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
TCMD vs BSX-PA Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, TCMD's ROE is +0.11%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, TCMD is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
TCMD vs ABT Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ABT has a market cap of 174.9B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ABT trades at $101.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ABT's P/E ratio is 19.40. In terms of profitability, TCMD's ROE is +0.11%, compared to ABT's ROE of +0.11%. Regarding short-term risk, TCMD is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ABT's competition here
Medtronic plc (NYSE: MDT)
TCMD vs MDT Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, MDT has a market cap of 113.3B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while MDT trades at $88.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas MDT's P/E ratio is 16.00. In terms of profitability, TCMD's ROE is +0.11%, compared to MDT's ROE of +0.11%. Regarding short-term risk, TCMD is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
TCMD vs SYK Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SYK has a market cap of 103.5B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SYK trades at $269.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SYK's P/E ratio is 20.16. In terms of profitability, TCMD's ROE is +0.11%, compared to SYK's ROE of +0.16%. Regarding short-term risk, TCMD is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
TCMD vs BSX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BSX has a market cap of 66.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BSX trades at $44.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BSX's P/E ratio is 14.42. In terms of profitability, TCMD's ROE is +0.11%, compared to BSX's ROE of +0.15%. Regarding short-term risk, TCMD is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
TCMD vs EW Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, EW has a market cap of 49.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while EW trades at $85.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas EW's P/E ratio is 31.74. In terms of profitability, TCMD's ROE is +0.11%, compared to EW's ROE of +0.10%. Regarding short-term risk, TCMD is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
TCMD vs DXCM Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, DXCM has a market cap of 33B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while DXCM trades at $87.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas DXCM's P/E ratio is 34.30. In terms of profitability, TCMD's ROE is +0.11%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, TCMD is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
TCMD vs GEHC Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, GEHC has a market cap of 30B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while GEHC trades at $66.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas GEHC's P/E ratio is 14.56. In terms of profitability, TCMD's ROE is +0.11%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, TCMD is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
TCMD vs PHG Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, PHG has a market cap of 24B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while PHG trades at $24.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas PHG's P/E ratio is 14.02. In terms of profitability, TCMD's ROE is +0.11%, compared to PHG's ROE of +0.10%. Regarding short-term risk, TCMD is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
TCMD vs ZBH Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ZBH has a market cap of 17.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ZBH trades at $89.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ZBH's P/E ratio is 10.58. In terms of profitability, TCMD's ROE is +0.11%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, TCMD is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
TCMD vs ABMD Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ABMD's P/E ratio is 65.36. In terms of profitability, TCMD's ROE is +0.11%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, TCMD is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
TCMD vs PEN Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while PEN trades at $319.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas PEN's P/E ratio is 83.48. In terms of profitability, TCMD's ROE is +0.11%, compared to PEN's ROE of +0.11%. Regarding short-term risk, TCMD is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
TCMD vs SWAV Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SWAV's P/E ratio is 78.76. In terms of profitability, TCMD's ROE is +0.11%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, TCMD is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
TCMD vs SNN Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SNN has a market cap of 11.2B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SNN trades at $26.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SNN's P/E ratio is 18.01. In terms of profitability, TCMD's ROE is +0.11%, compared to SNN's ROE of +0.12%. Regarding short-term risk, TCMD is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
TCMD vs ALGN Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ALGN has a market cap of 10.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ALGN trades at $145.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ALGN's P/E ratio is 13.27. In terms of profitability, TCMD's ROE is +0.11%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, TCMD is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
TCMD vs BIO Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BIO has a market cap of 10.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BIO trades at $387.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BIO's P/E ratio is 41.73. In terms of profitability, TCMD's ROE is +0.11%, compared to BIO's ROE of +0.03%. Regarding short-term risk, TCMD is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
TCMD vs BIO-B Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BIO-B has a market cap of 10.3B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BIO-B trades at $374.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BIO-B's P/E ratio is -65.99. In terms of profitability, TCMD's ROE is +0.11%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, TCMD is less volatile compared to BIO-B. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BIO-B's competition here
Globus Medical, Inc. (NYSE: GMED)
TCMD vs GMED Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, GMED has a market cap of 10B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while GMED trades at $74.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas GMED's P/E ratio is 16.73. In terms of profitability, TCMD's ROE is +0.11%, compared to GMED's ROE of +0.12%. Regarding short-term risk, TCMD is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
TCMD vs BRKR Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BRKR has a market cap of 9.7B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BRKR trades at $64.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BRKR's P/E ratio is 32.17. In terms of profitability, TCMD's ROE is +0.11%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, TCMD is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BRKR's competition here
Masimo Corporation (NASDAQ: MASI)
TCMD vs MASI Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas MASI's P/E ratio is 44.43. In terms of profitability, TCMD's ROE is +0.11%, compared to MASI's ROE of +0.09%. Regarding short-term risk, TCMD is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check MASI's competition here
Insulet Corp. (NASDAQ: PODD)
TCMD vs PODD Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, PODD has a market cap of 9.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while PODD trades at $135.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas PODD's P/E ratio is 23.13. In terms of profitability, TCMD's ROE is +0.11%, compared to PODD's ROE of +0.27%. Regarding short-term risk, TCMD is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PODD's competition here
Bruker Corporation (NASDAQ: BRKRP)
TCMD vs BRKRP Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BRKRP has a market cap of 9.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BRKRP trades at $468.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BRKRP's P/E ratio is 254.78. In terms of profitability, TCMD's ROE is +0.11%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, TCMD is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BRKRP's competition here
Glaukos Corporation (NYSE: GKOS)
TCMD vs GKOS Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, GKOS has a market cap of 9.1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while GKOS trades at $154.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas GKOS's P/E ratio is -180.02. In terms of profitability, TCMD's ROE is +0.11%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, TCMD is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check GKOS's competition here
Haemonetics Corporation (NYSE: HAE)
TCMD vs HAE Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while HAE trades at $106.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas HAE's P/E ratio is 21.15. In terms of profitability, TCMD's ROE is +0.11%, compared to HAE's ROE of +0.11%. Regarding short-term risk, TCMD is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
TCMD vs NARI Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas NARI's P/E ratio is -59.24. In terms of profitability, TCMD's ROE is +0.11%, compared to NARI's ROE of -0.00%. Regarding short-term risk, TCMD is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
TCMD vs ITGR Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ITGR trades at $126.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ITGR's P/E ratio is 19.87. In terms of profitability, TCMD's ROE is +0.11%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, TCMD is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
TCMD vs LIVN Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, LIVN has a market cap of 4.1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while LIVN trades at $75.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas LIVN's P/E ratio is 17.92. In terms of profitability, TCMD's ROE is +0.11%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, TCMD is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
TCMD vs IRTC Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while IRTC trades at $110.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas IRTC's P/E ratio is -257.67. In terms of profitability, TCMD's ROE is +0.11%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, TCMD is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
TCMD vs AXNX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas AXNX's P/E ratio is -709.80. In terms of profitability, TCMD's ROE is +0.11%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, TCMD is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check AXNX's competition here
Neogen Corporation (NASDAQ: NEOG)
TCMD vs NEOG Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while NEOG trades at $13.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas NEOG's P/E ratio is 48.79. In terms of profitability, TCMD's ROE is +0.11%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, TCMD is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check NEOG's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
TCMD vs TMDX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while TMDX trades at $83.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas TMDX's P/E ratio is 42.59. In terms of profitability, TCMD's ROE is +0.11%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, TCMD is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check TMDX's competition here
Butterfly Network, Inc. (NYSE: BFLY)
TCMD vs BFLY Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BFLY has a market cap of 2.5B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BFLY trades at $9.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BFLY's P/E ratio is -39.19. In terms of profitability, TCMD's ROE is +0.11%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, TCMD is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
TCMD vs AXGN Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while AXGN trades at $43.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas AXGN's P/E ratio is 114.00. In terms of profitability, TCMD's ROE is +0.11%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, TCMD is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
TCMD vs UFPT Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while UFPT trades at $298.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas UFPT's P/E ratio is 30.49. In terms of profitability, TCMD's ROE is +0.11%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, TCMD is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
TCMD vs NUVA Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas NUVA's P/E ratio is 75.00. In terms of profitability, TCMD's ROE is +0.11%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, TCMD is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
TCMD vs INSP Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while INSP trades at $68.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas INSP's P/E ratio is 30.31. In terms of profitability, TCMD's ROE is +0.11%, compared to INSP's ROE of +0.18%. Regarding short-term risk, TCMD is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
TCMD vs ESTA Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ESTA trades at $65.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ESTA's P/E ratio is -52.08. In terms of profitability, TCMD's ROE is +0.11%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, TCMD is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
TCMD vs NVCR Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while NVCR trades at $16.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas NVCR's P/E ratio is -12.46. In terms of profitability, TCMD's ROE is +0.11%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, TCMD is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
TCMD vs ATEC Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ATEC trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ATEC's P/E ratio is -165.33. In terms of profitability, TCMD's ROE is +0.11%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, TCMD is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
TCMD vs CNMD Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while CNMD trades at $45.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas CNMD's P/E ratio is 9.93. In terms of profitability, TCMD's ROE is +0.11%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, TCMD is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
TCMD vs HSKA Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas HSKA's P/E ratio is -62.49. In terms of profitability, TCMD's ROE is +0.11%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, TCMD is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
TCMD vs IART Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, IART has a market cap of 1.2B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while IART trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas IART's P/E ratio is 6.73. In terms of profitability, TCMD's ROE is +0.11%, compared to IART's ROE of -0.01%. Regarding short-term risk, TCMD is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
TCMD vs AVNS Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas AVNS's P/E ratio is 27.77. In terms of profitability, TCMD's ROE is +0.11%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, TCMD is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check AVNS's competition here
Artivion, Inc. (NYSE: AORT)
TCMD vs AORT Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while AORT trades at $23.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas AORT's P/E ratio is 38.40. In terms of profitability, TCMD's ROE is +0.11%, compared to AORT's ROE of -0.01%. Regarding short-term risk, TCMD is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check AORT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
TCMD vs SILK Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SILK's P/E ratio is -18.96. In terms of profitability, TCMD's ROE is +0.11%, compared to SILK's ROE of -0.35%. Regarding short-term risk, TCMD is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
TCMD vs FNA Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas FNA's P/E ratio is -19.83. In terms of profitability, TCMD's ROE is +0.11%, compared to FNA's ROE of -0.35%. Regarding short-term risk, TCMD is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
TCMD vs IRMD Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while IRMD trades at $85.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas IRMD's P/E ratio is 42.81. In terms of profitability, TCMD's ROE is +0.11%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, TCMD is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check IRMD's competition here
Enovis Corporation (NYSE: ENOV)
TCMD vs ENOV Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ENOV trades at $18.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ENOV's P/E ratio is 5.24. In terms of profitability, TCMD's ROE is +0.11%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, TCMD is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ENOV's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
TCMD vs TNDM Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, TNDM has a market cap of 1B. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while TNDM trades at $15.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas TNDM's P/E ratio is -16.37. In terms of profitability, TCMD's ROE is +0.11%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, TCMD is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check TNDM's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
TCMD vs PRCT Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, PRCT has a market cap of 996.1M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while PRCT trades at $17.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas PRCT's P/E ratio is -9.02. In terms of profitability, TCMD's ROE is +0.11%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, TCMD is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PRCT's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
TCMD vs BBNX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BBNX has a market cap of 979M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BBNX trades at $21.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BBNX's P/E ratio is -13.19. In terms of profitability, TCMD's ROE is +0.11%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, TCMD is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BBNX's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
TCMD vs LMRI Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, LMRI has a market cap of 949.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while LMRI trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas LMRI's P/E ratio is -19.22. In terms of profitability, TCMD's ROE is +0.11%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, TCMD is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check LMRI's competition here
Bioventus Inc. (NASDAQ: BVS)
TCMD vs BVS Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BVS has a market cap of 916M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BVS trades at $13.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BVS's P/E ratio is 17.79. In terms of profitability, TCMD's ROE is +0.11%, compared to BVS's ROE of +0.28%. Regarding short-term risk, TCMD is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
TCMD vs CBLL Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, CBLL has a market cap of 903.8M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while CBLL trades at $23.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas CBLL's P/E ratio is -13.53. In terms of profitability, TCMD's ROE is +0.11%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, TCMD is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CBLL's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
TCMD vs CSII Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas CSII's P/E ratio is -20.83. In terms of profitability, TCMD's ROE is +0.11%, compared to CSII's ROE of -0.14%. Regarding short-term risk, TCMD is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
TCMD vs SIBN Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SIBN has a market cap of 821.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SIBN trades at $18.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SIBN's P/E ratio is -54.47. In terms of profitability, TCMD's ROE is +0.11%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, TCMD is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
TCMD vs INMD Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, INMD has a market cap of 815.7M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while INMD trades at $14.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas INMD's P/E ratio is 9.85. In terms of profitability, TCMD's ROE is +0.11%, compared to INMD's ROE of +0.12%. Regarding short-term risk, TCMD is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
TCMD vs VREX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas VREX's P/E ratio is 19.44. In terms of profitability, TCMD's ROE is +0.11%, compared to VREX's ROE of +0.05%. Regarding short-term risk, TCMD is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
TCMD vs AHCO Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, AHCO has a market cap of 757.8M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while AHCO trades at $5.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas AHCO's P/E ratio is 11.37. In terms of profitability, TCMD's ROE is +0.11%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, TCMD is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check AHCO's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
TCMD vs AVR Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, AVR has a market cap of 743.8M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while AVR trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas AVR's P/E ratio is -3.94. In terms of profitability, TCMD's ROE is +0.11%, compared to AVR's ROE of -0.78%. Regarding short-term risk, TCMD is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check AVR's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
TCMD vs CTKB Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, CTKB has a market cap of 740M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while CTKB trades at $5.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas CTKB's P/E ratio is -30.36. In terms of profitability, TCMD's ROE is +0.11%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, TCMD is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
TCMD vs SRDX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SRDX's P/E ratio is -34.66. In terms of profitability, TCMD's ROE is +0.11%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, TCMD is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SRDX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
TCMD vs SSII Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SSII has a market cap of 590.4M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SSII trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SSII's P/E ratio is -49.17. In terms of profitability, TCMD's ROE is +0.11%, compared to SSII's ROE of -0.27%. Regarding short-term risk, TCMD is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check SSII's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
TCMD vs KIDS Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, KIDS has a market cap of 581.5M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while KIDS trades at $22.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas KIDS's P/E ratio is -19.19. In terms of profitability, TCMD's ROE is +0.11%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, TCMD is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
TCMD vs APEN Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas APEN's P/E ratio is -9.43. In terms of profitability, TCMD's ROE is +0.11%, compared to APEN's ROE of -0.85%. Regarding short-term risk, TCMD is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
TCMD vs DCTH Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, DCTH has a market cap of 555.1M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while DCTH trades at $16.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas DCTH's P/E ratio is 1608.00. In terms of profitability, TCMD's ROE is +0.11%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, TCMD is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
TCMD vs ZIMV Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, TCMD's ROE is +0.11%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, TCMD is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
TCMD vs CERS Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, CERS has a market cap of 525M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while CERS trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas CERS's P/E ratio is -86.54. In terms of profitability, TCMD's ROE is +0.11%, compared to CERS's ROE of -0.10%. Regarding short-term risk, TCMD is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CERS's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
TCMD vs PACB Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, PACB has a market cap of 490.8M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while PACB trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas PACB's P/E ratio is -3.85. In terms of profitability, TCMD's ROE is +0.11%, compared to PACB's ROE of -49.62%. Regarding short-term risk, TCMD is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PACB's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
TCMD vs NPCE Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, NPCE has a market cap of 476.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while NPCE trades at $13.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas NPCE's P/E ratio is -24.51. In terms of profitability, TCMD's ROE is +0.11%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, TCMD is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
TCMD vs SGHT Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SGHT has a market cap of 472.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SGHT trades at $8.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SGHT's P/E ratio is -15.50. In terms of profitability, TCMD's ROE is +0.11%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, TCMD is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check SGHT's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
TCMD vs CLPT Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, CLPT has a market cap of 437.8M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while CLPT trades at $14.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas CLPT's P/E ratio is -12.37. In terms of profitability, TCMD's ROE is +0.11%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, TCMD is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
TCMD vs SENS Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SENS has a market cap of 432.2M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SENS trades at $10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SENS's P/E ratio is -4.64. In terms of profitability, TCMD's ROE is +0.11%, compared to SENS's ROE of -1.66%. Regarding short-term risk, TCMD is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
TCMD vs OFIX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, OFIX has a market cap of 370.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while OFIX trades at $9.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas OFIX's P/E ratio is -5.97. In terms of profitability, TCMD's ROE is +0.11%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, TCMD is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check OFIX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
TCMD vs SMLR Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas SMLR's P/E ratio is 3.92. In terms of profitability, TCMD's ROE is +0.11%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, TCMD is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SMLR's competition here
CapsoVision, Inc. (NASDAQ: CV)
TCMD vs CV Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, CV has a market cap of 308.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while CV trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas CV's P/E ratio is -9.79. In terms of profitability, TCMD's ROE is +0.11%, compared to CV's ROE of -1.78%. Regarding short-term risk, TCMD is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CV's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
TCMD vs TMCI Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, TMCI has a market cap of 294.5M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while TMCI trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas TMCI's P/E ratio is -4.83. In terms of profitability, TCMD's ROE is +0.11%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, TCMD is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check TMCI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
TCMD vs RCEL Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, RCEL has a market cap of 287.7M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while RCEL trades at $11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas RCEL's P/E ratio is -8.04. In terms of profitability, TCMD's ROE is +0.11%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, TCMD is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check RCEL's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
TCMD vs CATX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, CATX has a market cap of 284.5M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while CATX trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas CATX's P/E ratio is -1.88. In terms of profitability, TCMD's ROE is +0.11%, compared to CATX's ROE of -0.42%. Regarding short-term risk, TCMD is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
TCMD vs TLSI Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, TLSI has a market cap of 283.9M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while TLSI trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas TLSI's P/E ratio is -2.74. In terms of profitability, TCMD's ROE is +0.11%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, TCMD is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check TLSI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
TCMD vs INFU Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, INFU has a market cap of 256.2M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while INFU trades at $12.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas INFU's P/E ratio is 30.96. In terms of profitability, TCMD's ROE is +0.11%, compared to INFU's ROE of +0.15%. Regarding short-term risk, TCMD is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
TCMD vs MGRM Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas MGRM's P/E ratio is -12.00. In terms of profitability, TCMD's ROE is +0.11%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, TCMD is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
TCMD vs ELMD Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ELMD has a market cap of 230.5M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ELMD trades at $27.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ELMD's P/E ratio is 21.25. In terms of profitability, TCMD's ROE is +0.11%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, TCMD is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
TCMD vs NVRO Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas NVRO's P/E ratio is -1.91. In terms of profitability, TCMD's ROE is +0.11%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, TCMD is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
TCMD vs PROF Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, PROF has a market cap of 203.5M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while PROF trades at $5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas PROF's P/E ratio is -5.71. In terms of profitability, TCMD's ROE is +0.11%, compared to PROF's ROE of -0.56%. Regarding short-term risk, TCMD is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PROF's competition here
Neuronetics, Inc. (NASDAQ: STIM)
TCMD vs STIM Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, STIM has a market cap of 196.2M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while STIM trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas STIM's P/E ratio is -6.41. In terms of profitability, TCMD's ROE is +0.11%, compared to STIM's ROE of -1.51%. Regarding short-term risk, TCMD is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check STIM's competition here
RxSight, Inc. (NASDAQ: RXST)
TCMD vs RXST Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, RXST has a market cap of 195.8M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while RXST trades at $4.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas RXST's P/E ratio is -4.19. In terms of profitability, TCMD's ROE is +0.11%, compared to RXST's ROE of -0.17%. Regarding short-term risk, TCMD is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
TCMD vs BSGM Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas BSGM's P/E ratio is -5.81. In terms of profitability, TCMD's ROE is +0.11%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, TCMD is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
TCMD vs MDGS Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas MDGS's P/E ratio is -0.27. In terms of profitability, TCMD's ROE is +0.11%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, TCMD is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
TCMD vs FOCL Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, FOCL has a market cap of 172M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while FOCL trades at $4.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas FOCL's P/E ratio is -4.44. In terms of profitability, TCMD's ROE is +0.11%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, TCMD is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
TCMD vs QIPT Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas QIPT's P/E ratio is -15.87. In terms of profitability, TCMD's ROE is +0.11%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, TCMD is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
TCMD vs LUCD Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, LUCD has a market cap of 159.9M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while LUCD trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas LUCD's P/E ratio is -2.26. In terms of profitability, TCMD's ROE is +0.11%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, TCMD is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check LUCD's competition here
Quantum-Si incorporated (NASDAQ: QSI)
TCMD vs QSI Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, QSI has a market cap of 157.7M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while QSI trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas QSI's P/E ratio is -1.73. In terms of profitability, TCMD's ROE is +0.11%, compared to QSI's ROE of -0.47%. Regarding short-term risk, TCMD is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check QSI's competition here
Quanterix Corporation (NASDAQ: QTRX)
TCMD vs QTRX Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, QTRX has a market cap of 149.8M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while QTRX trades at $3.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas QTRX's P/E ratio is -1.25. In terms of profitability, TCMD's ROE is +0.11%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, TCMD is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
TCMD vs INGN Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, INGN has a market cap of 141.6M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while INGN trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas INGN's P/E ratio is -5.75. In terms of profitability, TCMD's ROE is +0.11%, compared to INGN's ROE of -0.13%. Regarding short-term risk, TCMD is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
TCMD vs ICAD Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ICAD's P/E ratio is -20.37. In terms of profitability, TCMD's ROE is +0.11%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, TCMD is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
TCMD vs ECOR Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ECOR has a market cap of 102.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ECOR trades at $11.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ECOR's P/E ratio is -6.76. In terms of profitability, TCMD's ROE is +0.11%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, TCMD is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
TCMD vs HJLI Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas HJLI's P/E ratio is N/A. In terms of profitability, TCMD's ROE is +0.11%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, TCMD is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
TCMD vs ASXC Comparison September 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 516.3M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, TCMD is priced at $22.89 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 21.19, whereas ASXC's P/E ratio is -1.12. In terms of profitability, TCMD's ROE is +0.11%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, TCMD is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ASXC's competition here